Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Business Insights | The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses

The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses

The emerging global market for biosimilars market grew 5.9% to reach a value of approximately $1bn in 2007. In the near term, four drug classes including erythropoietin, filgrastim, human growth hormone (hGH) and insulin, will drive the growth of biosimilars. Based on 2007 sales reported by IMS, biologics worth $25bn are expected to go off-patent by 2016, thus creating a significant market opportunity for biosimilars. This report provides an overview of the global biosimilars market, including its size, various business strategies adopted by the top 10 companies, current industry trends and future opportunities. It also discusses the biosimilars approval process in the US, EU and major semi-regulated markets. This report ranks the top 10 companies based on their sales in the 1H 2008 and maps their marketed and pipeline products across the off-patent biologics categories. It also highlights the factors that will either drive or inhibit the growth of biosimilars.

Published: April 2009 - Global. PDF
Table of Contents
Price: $3,835.00 / €2,565.62

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions